Beta‐blockers in patients with refractory ascites: To treat or not to treat. That is the question? But, what is the answer?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|56|1|384-386

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.56, Iss.1, 2012-07, pp. : 384-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta‐blockers

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1486-1487

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of Beta-Blockers Action in Patients with Heart Failure

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 58-60

Bentham Science Publishers

Access to resources Recommend Favorite

Is Pretreatment with Beta-Blockers Beneficial in Patients with Acute Coronary Syndrome?

By  

Cardiology, Vol. 115, Iss. 2, 2009-11 ,pp. : 91-97

Karger

Access to resources Recommend Favorite

Benefits of beta‐blockers for patients with cirrhosis and infection: do not celebrate too soon!

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1777-1778

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beta‐blockers in patients with cirrhosis and infections: don't blame too soon!

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1778-1779

John Wiley & Sons Inc

Access to resources Recommend Favorite